UBS Group Portfolio holdings
UBS Group is the Swiss bank holding company behind UBS, which was created in 1998 when Union Bank of Switzerland merged with Swiss Bank Corporation; the holding company was listed in New York in 2014. Its business spans wealth management, investment banking, asset management and banking for individuals and companies. Its asset management arm offers stock, bond, currency, hedge fund, real estate, infrastructure and private equity strategies, which can also be combined in multi-asset portfolios. The group's roots go back to the Bank in Winterthur, founded in 1862, and to Swiss Bank Corporation, started by six private bankers in Basel by 1854. The wealth management arm serves high net worth individuals worldwide, and its US business grew out of Paine Webber, the American brokerage UBS merged with in 2000 and renamed UBS Wealth Management USA in 2003. In 2023 UBS took over Credit Suisse in a rescue deal arranged by the Swiss government and central bank.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.15B |
| 2 |
HONA
Honeywell Aerospace
HONA
|
+$611M |
| 3 |
SpaceX
SPCX
|
+$567M |
| 4 |
Apple
AAPL
|
+$511M |
| 5 |
Jabil
JBL
|
+$463M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$1.49B |
| 2 |
Western Digital
WDC
|
+$1.42B |
| 3 |
Lumentum
LITE
|
+$951M |
| 4 |
Intel
INTC
|
+$785M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$749M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 41.93% |
| 2 | Technology | 18.61% |
| 3 | Financials | 7.85% |
| 4 | Industrials | 6.96% |
| 5 | Healthcare | 5.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1351
CALL
Occidental Petroleum
OXY
$60.4B
| $75.1M | 0.01% |
1,546,050
+310,394
| +25% | +$17.6M |
2016 Q2
40 quarters
|
|
1352
Spyre Therapeutics
SYRE
$8.93B
| $74.8M | 0.01% |
843,071
+171,836
| +26% | +$12.5M |
2023 Q4
10 quarters
|
|
1353
Celsius Holdings
CELH
$7.59B
| $74.8M | 0.01% |
2,554,925
+1,146,165
| +81% | +$36.1M |
2017 Q2
36 quarters
|
|
1354
Xometry
XMTR
$5.47B
| $74.4M | 0.01% |
771,312
+348,989
| +83% | +$24.9M |
2021 Q3
19 quarters
|
|
1355
LyondellBasell Industries
LYB
$21.4B
| $74.4M | 0.01% |
1,413,598
-1,415,098
| -50% | -$97.7M |
2014 Q4
46 quarters
|
|
1356
PUT
Datadog
DDOG
$79.2B
| $74.4M | 0.01% |
285,800
+127,300
| +80% | +$23.7M |
2020 Q1
25 quarters
|
|
1357
Tradeweb Markets
TW
$26.2B
| $74.4M | 0.01% |
746,296
-1,182,404
| -61% | -$128M |
2019 Q2
28 quarters
|
|
1358
iShares US Home Construction ETF
ITB
$2.39B
| $74.3M | 0.01% |
711,238
+122,338
| +21% | +$11.6M |
2014 Q4
46 quarters
|
|
1359
PUT
Vistra
VST
$46.9B
| $74.3M | 0.01% |
468,400
+133,600
| +40% | +$20.7M |
2021 Q3
19 quarters
|
|
1360
PUT
Home Depot
HD
$333B
| $74.2M | 0.01% |
210,500
+5,600
| +3% | +$1.82M |
2014 Q4
46 quarters
|
|
1361
Hess Midstream
HESM
$4.2B
| $74.2M | 0.01% |
1,974,398
+10,399
| +0.5% | +$400K |
2017 Q2
36 quarters
|
|
1362
CALL
lululemon athletica
LULU
$12.4B
| $74.2M | 0.01% |
649,915
+430,609
| +196% | +$57.5M |
2023 Q1
13 quarters
|
|
1363
Xtrackers MSCI EAFE Hedged Equity ETF
DBEF
$9.28B
| $74.2M | 0.01% |
1,357,358
+66,026
| +5% | +$3.46M |
2014 Q4
46 quarters
|
|
1364
Banco Santander
SAN
$164B
| $74M | 0.01% |
5,360,914
-578,967
| -10% | -$7.18M |
2014 Q4
46 quarters
|
|
1365
XPO
XPO
$22.3B
| $73.9M | 0.01% |
359,996
-153,205
| -30% | -$32.4M |
2014 Q4
46 quarters
|
|
1366
XPeng
XPEV
$9.26B
| $73.9M | 0.01% |
5,580,085
+1,175,443
| +27% | +$18.6M |
2020 Q3
23 quarters
|
|
1367
Ormat Technologies
ORA
$5.79B
| $73.9M | 0.01% |
678,159
-418,439
| -38% | -$51.9M |
2014 Q4
46 quarters
|
|
1368
Sensata Technologies
ST
$6B
| $73.8M | 0.01% |
1,545,085
-312,675
| -17% | -$14.1M |
2014 Q4
46 quarters
|
|
1369
Haemonetics
HAE
$5.47B
| $73.8M | 0.01% |
983,378
+456,761
| +87% | +$29.3M |
2014 Q4
46 quarters
|
|
1370
BeOne Medicines Ltd
ONC
$40.2B
| $73.7M | 0.01% |
258,589
-156,741
| -38% | -$46.2M |
2017 Q1
37 quarters
|
|
1371
BioMarin Pharmaceuticals
BMRN
$11.1B
| $73.6M | 0.01% |
1,286,505
-210,347
| -14% | -$11.5M |
2014 Q4
46 quarters
|
|
1372
Vanguard Consumer Staples ETF
VDC
$8.17B
| $73.6M | 0.01% |
326,457
+10,724
| +3% | +$2.44M |
2014 Q4
46 quarters
|
|
1373
CALL
BILL Holdings
BILL
$4.27B
| $73.6M | 0.01% |
2,035,319
| – | – |
2024 Q2
8 quarters
|
|
1374
Inspire Medical Systems
INSP
$1.79B
| $73.4M | 0.01% |
1,645,511
+1,006,583
| +158% | +$47.7M |
2018 Q2
32 quarters
|
|
1375
Equity Lifestyle Properties
ELS
$11.8B
| $73.2M | 0.01% |
1,134,989
+181,321
| +19% | +$11.5M |
2014 Q4
46 quarters
|
|
Similar funds
UBS Group's Q2 2026 Portfolio in Review
As of Q2 2026, UBS Group held 11,684 positions worth $786B, up 18% from $666B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
UBS Group's Q2 2026 filing shows 1,281 new, 4,217 increased, 4,362 reduced and 1,275 closed positions. Its largest new stake was Honeywell Aerospace: 2,768,136 shares worth $612M. The largest sale was ExxonMobil, an estimated $1.49B.
By sector, the portfolio is most concentrated in Miscellaneous at 42% of assets, up from 39% a quarter earlier, followed by Technology and Financials.
- UBS Group's largest Q2 2026 buy was Honeywell Aerospace: 2,768,136 shares worth $612M.
- UBS Group added most to Microsoft in Q2 2026, an estimated $1.15B increase.
- UBS Group's biggest Q2 2026 reduction was ExxonMobil, cutting an estimated $1.49B.
- UBS Group fully exited Hologic in Q2 2026, selling an estimated $385M.
- UBS Group's ten largest holdings make up 13% of its $786B portfolio in Q2 2026.
- UBS Group opened 1,281 new positions and closed 1,275 in Q2 2026.
- UBS Group's portfolio value rose 18% quarter-over-quarter to $786B.
Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.